NS · Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Pharmaceuticals & Biotechnology

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $590.70M, P/E ratio is 21.35, net margin is 4.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for BIOFILCHEM

Market cap
$590.70M
P/E ratio
21.35
Net margin
4.1%

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) — FAQ

What is Biofil Chemicals & Pharmaceuticals Ltd's market cap?

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) has a reported market cap of $590.70M (data as of 2026-07-10).

What is BIOFILCHEM's P/E ratio?

The price-to-earnings (P/E) ratio for Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is 21.35 (data as of 2026-07-10).

Does Biofil Chemicals & Pharmaceuticals Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM). Check the MyAverix Finance app for the latest dividend data.

What sector is Biofil Chemicals & Pharmaceuticals Ltd in?

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is BIOFILCHEM listed on?

BIOFILCHEM is listed on NS.

What is Biofil Chemicals & Pharmaceuticals Ltd's net margin?

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) reports a net margin of 4.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

App Store Google Play